⌘K
Loading ticker…
Vertex Pharmaceuticals Inc · Healthcare · Pharmaceutical Products
As of 2026-06-26, Vertex Pharmaceuticals Inc (VRTX) has a 3-month relative strength percentile of 55 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 53. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 2.6%, relative volume 5.98×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
55 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
VRTX is held by 19 ETFs as of Mar 2026. Top owner: VTI at 0.18% weight, $3.6B notional. Top 3 carry $8.9B.
Top 10 by value, from SEC N-PORT-P filings dated Mar 2026.
| ETF | Weight | Value |
|---|---|---|
| VTIVanguard Total Stock Market ETF | 0.18% | $3.6B |
| VOOVanguard S&P 500 ETF | 0.20% | $2.9B |
| QQQInvesco QQQ Trust Series I | 0.64% | $2.4B |
| IVViShares Core S&P 500 ETF | 0.20% | $1.5B |
| SPYState Street SPDR S&P 500 ETF | 0.20% | $1.3B |
| VUGVanguard Growth ETF | 0.39% | $1.2B |
| XLVState Street Health Care Select Sector SPDR ETF | 2.14% | $825M |
| JEPIJPMorgan Equity Premium Income ETF | 1.24% | $544M |
| IWFiShares Russell 1000 Growth ETF | 0.41% | $457M |
| SPYMState Street SPDR Portfolio S&P 500 ETF | 0.20% | $238M |
Showing 10 of 19 ETF owners.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | VRTX Jan avg: 9.17% median: 9.20% win: 100% σ: 5.00% n: 4 2022-04-12 → 2026-05-29 | VRTX Feb avg: -0.85% median: 0.50% win: 50% σ: 7.23% n: 4 2022-04-12 → 2026-05-29 | VRTX Mar avg: -0.30% median: 0.20% win: 50% σ: 7.67% n: 4 2022-04-12 → 2026-05-29 | VRTX Apr avg: 0.02% median: -2.80% win: 40% σ: 6.22% n: 5 2022-04-12 → 2026-05-29 | VRTX May avg: 0.14% median: -1.67% win: 40% σ: 10.94% n: 5 2022-04-12 → 2026-05-29 | VRTX Jun avg: 4.32% median: 3.91% win: 100% σ: 3.41% n: 4 2022-04-12 → 2026-05-29 (current) | VRTX Jul avg: 2.00% median: 1.37% win: 75% σ: 2.84% n: 4 2022-04-12 → 2026-05-29 | VRTX Aug avg: -3.76% median: -0.55% win: 50% σ: 7.14% n: 4 2022-04-12 → 2026-05-29 | VRTX Sep avg: -0.87% median: -0.01% win: 50% σ: 3.80% n: 4 2022-04-12 → 2026-05-29 | VRTX Oct avg: 5.72% median: 5.95% win: 100% σ: 2.99% n: 4 2022-04-12 → 2026-05-29 | VRTX Nov avg: -0.09% median: -0.12% win: 50% σ: 2.03% n: 4 2022-04-12 → 2026-05-29 | VRTX Dec avg: -0.87% median: -2.09% win: 50% σ: 12.97% n: 4 2022-04-12 → 2026-05-29 |